StageZero Life Sciences Ltd.
SZLS
Peringkat dalam Saham
#36000
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Harga Saham
$0.02770208
Terakhir disinkronkan: 2025-03-10
Kapitalisasi Pasar
$2.92M
Perubahan (1 hari)
-0.46%
Perubahan (1 tahun)
443.18%
Negara
CA
Perdagangan StageZero Life Sciences Ltd. (SZLS)
Kategori
Healthcare
Riwayat harga saham StageZero Life Sciences Ltd. (SZLS)
Harga penutupan tertinggi: $0.00 pada 2026-10-01
Harga penutupan terendah: $2.81 pada 2009-09-01
Harga penutupan terendah: $2.81 pada 2009-09-01
Riwayat harga saham StageZero Life Sciences Ltd. dari 2009 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -73.56% |
| 2024 | -62.97% |
| 2023 | -33.87% |
| 2022 | -78.51% |
| 2021 | -55.53% |
| 2020 | 1,478.24% |
| 2019 | 52.97% |
| 2018 | -82.67% |
| 2017 | -60.46% |
| 2016 | 1,319.73% |
| 2015 | -98.57% |
| 2014 | 178.20% |
| 2013 | -10.96% |
| 2012 | -45.98% |
| 2011 | -18.68% |
| 2010 | -42.93% |
| 2009 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
